title: Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.
authors.affiliation: Probity Medical Research, Waterloo, Ontario, Canada. kapapp@probitymedical.com
authors.forename: Kim A
authors.initials: KA
authors.lastname: Papp
authors.forename: James
authors.initials: J
authors.lastname: Signorovitch
authors.forename: Karthik
authors.initials: K
authors.lastname: Ramakrishnan
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Yu
authors.forename: Shiraz R
authors.initials: SR
authors.lastname: Gupta
authors.forename: Yanjun
authors.initials: Y
authors.lastname: Bao
authors.forename: Parvez M
authors.initials: PM
authors.lastname: Mulani